This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
University of Utah researchers have characterized a protein that may help protect spinal disks from age-related damage, pointing to a possible direction for future back pain treatments. Using CRISPR to target ZNF865, also known as BLST, in human cells and mouse and rat models, the interdisciplinary team showed how increasing or decreasing BLST levels affected spinal disk health.
Led by Robby D. Bowles, an associate professor of biomedical engineering, the study is the first functional characterization of the gene and protein. Additional preclinical studies and, eventually, clinical trials are needed to determine whether targeting BLST with CRISPR could be safe and effective in people.
"This paper directly shows a novel understanding that DNA damage is a driver of back pain, and that we can regulate BLST therapeutically with CRISPR," Bowles said. "Back pain is the number three leading cause of disability as measured by disability-adjusted life years, only behind cardiac disease and drug use disorders."
Bowles and members of his lab in the John and Marcia Price College of Engineering collaborated with researchers specializing in orthopedics and arthritis at the Spencer Fox Eccles School of Medicine and with other university researchers at Huntsman Cancer Institute at the University of Utah. The mechanisms identified in the study could also inform research into DNA damage associated with cancer.
The study found that levels of BLST were lower in older and damaged spinal disks, the cushionlike structures between vertebrae that allow the spine to move.
Source link







